Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2012; 33(01): 58-59
DOI: 10.4103/0971-5851.96974
LETTERS TO EDITOR

Programmable morphine pump (an intrathecal drug delivery system) - A promising option for pain relief and palliation in cancer patients

Manish Singh
Department of Neurosurgery, JIPMER, Puducherry, India
,
Goutham Cugati
Dr. Achanta Lakshmipathi Neurosurgical Centre, Post Graduate Institute of Neurological Surgery, VHS Hospital, Taramani, Chennai, Tamil Nadu, India
,
Pratibha Singh
Department of Obstetrics and Gynecology, JIPMER, Puducherry, India
,
Ajai Singh
Department of Neurology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Vibhooti Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
13 April 2022

© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Lee KS, Chu KS, Chung CL, Lin CL, Hwang SL, Howng SL. Intrathecaldrug delivery system with programmable morphine pump for pain of terminally Ill cancer patients. J Chinese Oncol 2009;25:159-66.
  • 2 Stjernsward J, Colleau SM, Ventafridda V. The World Health Organization cancer pain and palliative care program: Past, present and future. J Pain Symptom Manage 1996;12:65-72.
  • 3 Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, et al., Intrathecal Drug Delivery for the management of Cancer Pain A Multidisciplinary Consensus of Best Clinical Practices. J Support Oncol 2005;3:399-408.
  • 4 Greenberg MS. Handbook of neurosurgery: Pain. 6 th ed, New York: Thieme Medical Publishers; 2006. p. 376-400.
  • 5 Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery system. J Pain Symptom Manage 2000;19:209-15.
  • 6 Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, et al. An implantable drug delivery system for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management. Ann Oncol 2005;16:825-33.
  • 7 Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991;6:368-73.
  • 8 Erdine S, Talu GK. Cost effectiveness of implantable devices versus tunneled catheters. Curr Rev Pain 1998;2:157-62.